Jose-Carlos Gutierrez-Ramos - 01 Apr 2022 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
Director
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Jose-Carlos Gutierrez-Ramos
Issuer symbol
EVLO on OTC
Transactions as of
01 Apr 2022
Net transactions value
$0
Form type
4
Filing time
05 Apr 2022, 17:41:41 UTC
Previous filing
28 Feb 2022
Next filing
02 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 01 Apr 2022 Common Stock 40,000 $3.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 36 substantially equal monthly installments following the grant date and has a term of 10 years.